Different Ways of Aging Not All Organisms Age at the Same Rate. In
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Lived Experience of Being a Hundred Years and Over
The lived experience of being a hundred years and over By Ashwina Naiker-Ratan A thesis submitted to Victoria University of Wellington in fulfilment of the requirements for the Degree of Master of Health Research Victoria University of Wellington 2016 ABSTRACT The twentieth century has seen a decline in mortality after the age of eighty and an increase in survival rates of the oldest of the old. Centenarians (people over a hundred years of age) are the fastest growing group of this population in developed countries; however qualitative research on the oldest of the old is limited. The primary aim of this study was to gain an understanding of the essence of lived experiences and meanings of extended longevity as perceived by centenarians. It also aimed to explore the role of lifestyle characteristics, family, social, health and cultural factors in regards to their prolonged existence. The research was conducted with ten centenarians aged between 100 and 106 years living in the Lower North Island namely Wairarapa, Kapiti and Wellington of Aotearoa New Zealand. Biographical Narrative Interpretive Method of inquiry was used to guide the data collection through face-to-face interviews using unstructured open ended questions. Colazzi’s phenomenological framework was employed for data analysis. There were common patterns throughout the life stories related by the centenarians and resilience and acceptance of life was notable. The centenarians spoke nonchalantly about their experience of turning a hundred, describing their birthday as; “Just another day.” Positive personalities and resilient nature were prominent features of the participants who all expressed a sense of acceptance and satisfaction with life and contentment with living in the present. -
Life-Span Trends in Olympians and Supercentenarians Juliana Antero, Geoffroy Berthelot, Adrien Marck, Philippe Noirez, Aurélien Latouche, Jean-François Toussaint
Learning From Leaders: Life-span Trends in Olympians and Supercentenarians Juliana Antero, Geoffroy Berthelot, Adrien Marck, Philippe Noirez, Aurélien Latouche, Jean-François Toussaint To cite this version: Juliana Antero, Geoffroy Berthelot, Adrien Marck, Philippe Noirez, Aurélien Latouche, et al.. Learn- ing From Leaders: Life-span Trends in Olympians and Supercentenarians. Journals of Gerontology, Series A, Oxford University Press (OUP): Policy B - Oxford Open Option D, 2015, 70 (8), pp.944-949. 10.1093/gerona/glu130. hal-01768388 HAL Id: hal-01768388 https://hal-insep.archives-ouvertes.fr/hal-01768388 Submitted on 17 Apr 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Journals of Gerontology: BIOLOGICAL SCIENCES © The Author 2014. Published by Oxford University Press on behalf of The Gerontological Society of America. Cite journal as: J Gerontol A Biol Sci Med Sci This is an Open Access article distributed under the terms of the Creative Commons Attribution doi:10.1093/gerona/glu130 Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), -
Disruptive Chemicals, Senescence and Immortality
Disruptive chemicals, senescence and immortality Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., ... & Yasaei, H. (2015). Disruptive chemicals, senescence and immortality. Carcinogenesis, 36(Suppl 1), S19-S37. doi:10.1093/carcin/bgv029 10.1093/carcin/bgv029 Oxford University Press Version of Record http://cdss.library.oregonstate.edu/sa-termsofuse Carcinogenesis, 2015, Vol. 36, Supplement 1, S19–S37 doi:10.1093/carcin/bgv029 Review review Disruptive chemicals, senescence and immortality Amancio Carnero*, Carmen Blanco-Aparicio1, Hiroshi Kondoh2, Matilde E. Lleonart3, Juan Fernando Martinez-Leal4, Chiara Mondello5, A.Ivana Scovassi5, William H.Bisson6, Amedeo Amedei7, Rabindra Roy8, Jordan Woodrick8, Annamaria Colacci9, Monica Vaccari9, Jayadev Raju10, Fahd Al-Mulla11, Rabeah Al- Downloaded from Temaimi11, Hosni K. Salem12, Lorenzo Memeo13, Stefano Forte13, Neetu Singh14, Roslida A. Hamid15, Elizabeth P. Ryan16, Dustin G. Brown16, John Pierce Wise Sr17, Sandra S.Wise17 and Hemad Yasaei18 http://carcin.oxfordjournals.org/ Instituto de Biomedicina de Sevilla (IBIS/CSIC/HUVR/Univ. Sevilla), Oncohematology and Genetics Department, Avda Manuel siurot sn, 41013 Sevilla, Spain, 1Spanish National Cancer Research Center, Experimental Therapuetics Department, Melchor Fernandez Almagro, 3, 28029 Madrid, Spain, 2Department of Geriatric Medicine, Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-ku Kyoto 606-8507, Japan, 3Institut De Recerca Hospital Vall D’Hebron, Passeig Vall d’Hebron, 119–129, -
The Emergence of Senescent Surface Biomarkers As Senotherapeutic Targets
cells Review The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets Martina Rossi and Kotb Abdelmohsen * Laboratory of Genetics and Genomics, RNA Regulation Section, National Institute on Aging Intramural Research Program, National Institutes of Health, 251 Bayview Blvd., Baltimore, MD 21224, USA; [email protected] * Correspondence: [email protected] Abstract: Senescence is linked to a wide range of age-associated diseases and physiological declines. Thus, senotherapeutics are emerging to suppress the detrimental effects of senescence either by senomorphics or senolytics. Senomorphics suppress the traits associated with senescence phenotypes, while senolytics aim to clear senescent cells by suppressing their survival and enhancing the apoptotic pathways. The main goal of these approaches is to suppress the proinflammatory senescence- associated secretory phenotype (SASP) and to promote the immune recognition and elimination of senescent cells. One increasingly attractive approach is the targeting of molecules or proteins specifically present on the surface of senescent cells. These proteins may play roles in the maintenance and survival of senescent cells and hence can be targeted for senolysis. In this review, we summarize the recent knowledge regarding senolysis with a focus on novel surface biomarkers of cellular senescence and discuss their emergence as senotherapeutic targets. Keywords: senescence; surface proteins; surfaceome; senolytics; senolysis; senostatic; senescent cell clearance; senotherapeutics; senotherapy Citation: Rossi, M.; Abdelmohsen, K. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets. Cells 2021, 10, 1740. 1. Introduction https://doi.org/10.3390/cells Cellular senescence is a phenotype associated with limited replicative capacity and 10071740 irreversible growth arrest of primary cells first described by Leonard Hayflick in the early 1960s [1]. -
Does Senescence Promote Fitness in Caenorhabditis Elegans by Causing Death?
Institute of Healthy Ageing Preprint 1st Nov 2018 Essay Does senescence promote fitness in Caenorhabditis elegans by causing death? Jennifer N. Lohr1, Evgeniy R. Galimov1 and David Gems* Institute of Healthy Ageing, and Research Department of Genetics, Evolution and Environment, University College London, London WC1E 6BT, UK. 1These authors contributed equally. ∗ Corresponding author. E-mail address: [email protected] (D. Gems). 1 Institute of Healthy Ageing Preprint 1st Nov 2018 Abstract A widely appreciated conclusion from evolutionary theory is that senescence (aging) is of no adaptive value to the individual that it afflicts. Yet studies of C. elegans and S. cerevisiae are increasingly revealing the presence of processes which actively cause senescence and death, leading some biogerontologists to wonder about the established theory. Here we argue that programmed death that increases fitness could occur in C. elegans and S. cerevisiae, and that this is consistent with the classic evolutionary theory of aging. This is because of the special conditions under which these organisms have evolved, particularly the existence of clonal populations with limited dispersal and, in the case of C. elegans, the brevity of the reproductive period caused by protandry. Under these conditions, death-promoting mechanisms could promote worm fitness by enhancing inclusive fitness, or worm colony fitness through group selection. Such altruistic, adaptive death is not expected to evolve in organisms with outbred, dispersed populations. The plausibility of adaptive death in C. elegans is supported by computer modelling studies, and new knowledge about the ecology of this species. To support these arguments we also review the biology of adaptive death, and distinguish three forms: consumer sacrifice, biomass sacrifice and defensive sacrifice. -
Living-100-Insights-Challenges.Pdf
Living to 100 Insights on the Challenges and Opportunities of Longevity Literature Review 2002–2017 April 2019 Living to 100 Insights on the Challenges and Opportunities of Longevity SPONSOR Research Expanding Boundaries Pool AUTHORS Sean She, FSA, MAAA Committee on Life Insurance Research Francisco J. Orduña, FSA, MAAA Product Development Section Peter Carlson, FSA, MAA Committee on Knowledge Extension Research 1 | P a g e This publication has been prepared for general informational purposes only; and is not intended to be relied upon as accounting, tax, financial or other professional advice. It is not intended to be a substitute for detailed research or the exercise of professional judgement. Please refer to your advisors for specific advice. Neither Ernst & Young LLP, the authors, nor any other member of Ernst & Young Global Limited can accept any responsibility or liability for loss occasioned to any person acting or refraining from action as a result of any material in this publication. Neither SOA, the authors nor Ernst & Young LLP recommend, encourage or endorse any particular use of the information provided in this publication. Neither SOA, the authors nor Ernst & Young LLP make any warranty, guarantee or representation whatsoever. None of SOA, the authors nor Ernst & Young LLP assume any responsibility or liability to any person or entity with respect to any losses arising in connection with the use or misuse of this publication. The opinions expressed and conclusions reached by the authors are their own and do not represent any official position or opinion of the Society of Actuaries or its members. The Society of Actuaries makes no representation or warranty to the accuracy of the information. -
Understanding the Molecular Interplay Between Senescence, Rejuvenation, and Healthy Ageing. Eleanor Tyler
Understanding the molecular interplay between senescence, rejuvenation, and healthy ageing. Eleanor Tyler A thesis presented for the degree of Doctor of Philosophy 2016 Supervisors: Dr Cleo L. Bishop Prof. Mike P. Philpott Centre for Cell Biology and Cutaneous Research The Blizard Institute Barts and the London School of Medicine and Dentistry Queen Mary University of London Statement of originality I, Eleanor Tyler, confirm that the research included within this thesis is my own work or that where it has been carried out in collaboration with, or supported by others, that this is duly acknowledged below and my contribution indicated. I attest that I have exercised reasonable care to ensure that the work is original, and does not to the best of my knowledge break any UK law, infringe any third party’s copyright or other Intellectual Property Right, or contain any confidential material. I accept that the College has the right to use plagiarism detection software to check the electronic version of the thesis. I confirm that this thesis has not been previously submitted for the award of a degree by this or any other university. The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author. Signature: Eleanor Tyler Date: 19.12.16 1 Abstract Senescence is classically defined as an irreversible cell cycle arrest. There is now convincing evidence that senescent cells accumulate during human ageing, potentially driving age-related dysfunction through depletion of mitotically active cells and stimulation of chronic inflammation. -
Dissecting Aging and Senescence—Current Concepts and Open Lessons
cells Review Dissecting Aging and Senescence—Current Concepts and Open Lessons 1,2, , 1,2, 1 1,2 Christian Schmeer * y , Alexandra Kretz y, Diane Wengerodt , Milan Stojiljkovic and Otto W. Witte 1,2 1 Hans-Berger Department of Neurology, Jena University Hospital, 07747 Jena, Thuringia, Germany; [email protected] (A.K.); [email protected] (D.W.); [email protected] (M.S.); [email protected] (O.W.W.) 2 Jena Center for Healthy Ageing, Jena University Hospital, 07747 Jena, Thuringia, Germany * Correspondence: [email protected] These authors have contributed equally. y Received: 2 October 2019; Accepted: 13 November 2019; Published: 15 November 2019 Abstract: In contrast to the programmed nature of development, it is still a matter of debate whether aging is an adaptive and regulated process, or merely a consequence arising from a stochastic accumulation of harmful events that culminate in a global state of reduced fitness, risk for disease acquisition, and death. Similarly unanswered are the questions of whether aging is reversible and can be turned into rejuvenation as well as how aging is distinguishable from and influenced by cellular senescence. With the discovery of beneficial aspects of cellular senescence and evidence of senescence being not limited to replicative cellular states, a redefinition of our comprehension of aging and senescence appears scientifically overdue. Here, we provide a factor-based comparison of current knowledge on aging and senescence, which we converge on four suggested concepts, thereby implementing the newly emerging cellular and molecular aspects of geroconversion and amitosenescence, and the signatures of a genetic state termed genosenium. -
Chapter 9. Myths of Life Extension
Chapter 9. Myths of Life Extension Ever since humans became fully aware that they will get old and die, individuals must have wondered about the possibility of extending longevity, or achieving immortality on earth. This has resulted in innumerable myths relating to supposed examples of life-extension, one of the most notable being the 969 year lifespan of Methuselah, as recorded in the Bible. Christian fundamentalists are liable to say that in those days people lived much longer than they do today! These are many other claims, and far too many to list here. The Guiness Book of Records has stated that maximum lifespans of people and animals are some of the hardest records to document. Some of the claims of human longevity have occurred in the 20th century, and as in some cases they were initially accepted by scientists, and they provide good examples of how people are deceived. Many people living in the Caucasus region of the ex-Soviet Union claimed their ages were over 120 years, or even 160 years. There was even a touring troup of centenarian dancers, so it is not surprising the claims received wide publicity, and also wide acceptance. The oldest people were usually males which is intrinsically unlikely as human females live longer that males. Careful scrutiny of these cases, particularly by the gerontologist Zhores Medvedev, has shown that none are backed up by reliable records. In some cases, individuals took on the identity of their father, in others they exaggerated their age to escape military conscription, or they simply added on years, because the societies in which they lived respected the wisdom and experience of very old people. -
Aging, Life Span, and Senescence
Proc. Natl. Acad. Sci. USA Vol. 95, pp. 11034–11036, September 1998 From the Academy This paper is summary of a session presented at the Ninth Annual Frontiers of Science Symposium, held November 7–9, 1997, at the Arnold and Mabel Beckman Center of the National Academies of Sciences and Engineering in Irvine, CA. Aging, life span, and senescence LEONARD GUARENTE*, GARY RUVKUN†, AND RICHARD AMASINO‡ *Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; †Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114; and ‡Department of Biochemistry, University of Wisconsin, Madison, WI 53706 Research in the field of aging recently has entered a new era. in old sgs1 mother cells were enlarged and fragmented, Model systems have begun to provide insight into cellular, changes that are also found in very old wild type cells. molecular, and organismal changes that are related intimately What is the molecular basis of this fragmentation and does to aging. One important approach has been the identification it cause aging? Examination of the rDNA in old cells revealed of genes that determine the life span of an organism. The very an accumulation of extrachromosomal rDNA circles (ERCs) existence of genes that when mutated can extend life span of discrete sizes representing oligomers of the rDNA unit (7). suggests that one or a few processes may be critical in aging and ERCs arise from recombination within the rDNA of chromo- that a slowing of these processes may slow aging itself. some XII in the early part of the life span (Fig. 1). Each subsequent cell cycle, the ERCs replicate via the replication Yeast sequence in the rDNA repeats and then segregate asymmetri- cally into mother cells. -
Controversy 2
Controversy 2 WHY DO OUR BODIES GROW OLD? liver Wendell Holmes (1858/1891), in his poem “The Wonderful One-Hoss Shay,” invokes a memorable image of longevity and mortality, the example of a wooden Ohorse cart or shay that was designed to be long-lasting: Have you heard of the wonderful one-hoss shay, That was built in such a logical way, It ran a hundred years to a day . ? This wonderful “one-hoss shay,” we learn, was carefully built so that every part of it “aged” at the same rate and didn’t wear out until the whole thing fell apart all at once. Exactly a century after the carriage was produced, the village parson was driving this marvelous machine down the street, when What do you think the parson found, When he got up and stared around? The poor old chaise in a heap or mound, As if it had been to the mill and ground! You see, of course, if you’re not a dunce, How it went to pieces all at once, All at once, and nothing first, Just as bubbles do when they burst. The wonderful one-horse shay is the perfect image of an optimistic hope about aging: a long, healthy existence followed by an abrupt end of life, with no decline. The one-horse shay image also suggests that life has a built-in “warranty expiration” date. But where does this limit on longevity come from? Is it possible to extend life beyond what we know? The living organism with the longest individual life span is the bristlecone pine tree found in California, more than 4,500 years old, with no end in sight. -
Increase of Human Longevity: Past, Present and Future
Increase of Human Longevity: Past, Present and Future John R. Wilmoth Department of Demography University of California, Berkeley Instute for Populaon and Social Security Research Tokyo, Japan 22 December 2009 Topics • Historical increase of longevity • Age paerns of mortality • Medical causes of death • Social and historical causes • Limits to the human life span? • Future prospects Historical Increase of Longevity Life Expectancy at Birth, 1950-2009 Data source: United Nations, World Population Prospects: 2008 Revision, 2009 Life Expectancy at Birth, France, 1816-2007 Data source: Human Mortality Database, 2009 (www.mortality.org) Life Expectancy at Birth, France and India, 19th and 20th C. Data sources: HMD, 2009; M. Bhat, 1989, 1998 & 2001; United Nations, 2009 Life Expectancy at Birth, 1950‐2007 W. Europe, USA, Canada, Australia, NZ, Japan Data source: Human Mortality Database, 2009 (www.mortality.org) Historical mortality levels Life expectancy Infant mortality rate at birth (in years) (per 1000 live births) Prehistoric 20-35 200-300 Sweden, 1750s 36 212 India, 1880s 25 230 U.S.A., 1900 48 133 France, 1950 66 52 Japan, 2007 83 <3 Source: J. Wilmoth, Encyclopedia of Population, 2003 (updated) Age Paerns of Mortality Death Rates by Age, U.S., 1900 & 1995 Data source: Social Security Administraon, United States Distribuon of Deaths, U.S., 1900 & 1995 Data source: Social Security Administraon, United States Probability of Survival, U.S., 1900 & 1995 Data source: Social Security Administraon, United States Dispersion of Ages at Death vs. Life Expectancy at Birth, Sweden 1751‐1995 70 80 60 70 Life Expectancy at Birth (in years) 50 Inter-quartile range 60 40 Life expectancy at birth 50 30 40 Inter-quartile Range (in years) 20 Women Men 30 1751-55 1791-95 1831-35 1871-75 1911-15 1951-55 1991-95 Year Source: J.